Home » Topics » Regulatory

Regulatory
RSS

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...